Literature DB >> 21193556

A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells.

David Langlais1, Catherine Couture, Guillaume Sylvain-Drolet, Jacques Drouin.   

Abstract

Cell-specific expression of the pituitary proopiomelanocortin (POMC) gene depends on the combination of tissue- and cell-restricted transcription factors such as Pitx1 and Tpit. These factors act on the proximal POMC promoter together with transcription factors that integrate inputs from signaling pathways. We now report the identification of an upstream enhancer in the POMC locus that is targeted by the same subset of transcription factors, except Pitx1. This enhancer located at -7 kb in the mouse POMC gene is highly dependent on Tpit for activity. Whereas Tpit requires Pitx1 for action on the promoter, it acts on the -7-kb enhancer as homodimers binding to a palindromic Tpit response element (TpitRE). Both half-sites of the TpitRE palindrome and Tpit homodimerization are required for activity. In vivo, the enhancer exhibits preferential activity in corticotrope cells of the anterior lobe whereas the promoter exhibits preference for intermediate lobe melanotropes. The enhancer is conserved among different species with the TpitRE palindrome localized at the center of conserved sequences. However, the mouse and human -7-kb enhancers do not exhibit conservation of hormone responsiveness and may differ in their relative importance for POMC expression. In summary, pituitary expression of the POMC gene relies on an upstream enhancer that complements the activity of the proximal promoter with Tpit as the major regulator of both regulatory regions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193556      PMCID: PMC5417307          DOI: 10.1210/me.2010-0422

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  32 in total

1.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

2.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

3.  Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.

Authors:  C Bousquet; M C Zatelli; S Melmed
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

4.  Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness.

Authors:  Eric Batsché; Julien Desroches; Steve Bilodeau; Yves Gauthier; Jacques Drouin
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

5.  Pituitary-specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice.

Authors:  G D Hammer; V Fairchild-Huntress; M J Low
Journal:  Mol Endocrinol       Date:  1990-11

6.  Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development.

Authors:  C Lanctôt; Y Gauthier; J Drouin
Journal:  Endocrinology       Date:  1999-03       Impact factor: 4.736

7.  Authentic cell-specific and developmentally regulated expression of pro-opiomelanocortin genomic fragments in hypothalamic and hindbrain neurons of transgenic mice.

Authors:  J I Young; V Otero; M G Cerdán; T L Falzone; E C Chan; M J Low; M Rubinstein
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

8.  Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin.

Authors:  Pierre-Luc Lavoie; Lionel Budry; Aurélio Balsalobre; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2008-04-03

9.  Tpit determines alternate fates during pituitary cell differentiation.

Authors:  Anne-Marie Pulichino; Sophie Vallette-Kasic; Judy Peih-Ying Tsai; Catherine Couture; Yves Gauthier; Jacques Drouin
Journal:  Genes Dev       Date:  2003-03-15       Impact factor: 11.361

10.  Regulatory network analyses reveal genome-wide potentiation of LIF signaling by glucocorticoids and define an innate cell defense response.

Authors:  David Langlais; Catherine Couture; Aurélio Balsalobre; Jacques Drouin
Journal:  PLoS Genet       Date:  2008-10-17       Impact factor: 5.917

View more
  22 in total

1.  Adult pituitary cell maintenance: lineage-specific contribution of self-duplication.

Authors:  David Langlais; Catherine Couture; Marie Kmita; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2013-06-10

2.  Evolution of transcriptional enhancers and animal diversity.

Authors:  Marcelo Rubinstein; Flávio S J de Souza
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-11-11       Impact factor: 6.237

Review 3.  Regulation of organogenesis and stem cell properties by T-box transcription factors.

Authors:  Yasuo Takashima; Atsushi Suzuki
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

4.  Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.

Authors:  Ning-Ai Liu; Takako Araki; Daniel Cuevas-Ramos; Jiang Hong; Anat Ben-Shlomo; Yukiko Tone; Masahide Tone; Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2015-05-05       Impact factor: 5.958

5.  E2F1-mediated human POMC expression in ectopic Cushing's syndrome.

Authors:  Takako Araki; Ning-Ai Liu; Yukiko Tone; Daniel Cuevas-Ramos; Roy Heltsley; Masahide Tone; Shlomo Melmed
Journal:  Endocr Relat Cancer       Date:  2016-10-07       Impact factor: 5.678

6.  Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning.

Authors:  Ghazala Begum; Adam Stevens; Emma Bolton Smith; Kristin Connor; John R G Challis; Frank Bloomfield; Anne White
Journal:  FASEB J       Date:  2012-01-05       Impact factor: 5.191

7.  Enhancer turnover and conserved regulatory function in vertebrate evolution.

Authors:  Sabina Domené; Viviana F Bumaschny; Flávio S J de Souza; Lucía F Franchini; Sofía Nasif; Malcolm J Low; Marcelo Rubinstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-11-11       Impact factor: 6.237

8.  Dmrt5 controls corticotrope and gonadotrope differentiation in the zebrafish pituitary.

Authors:  Martin Graf; Elizabeth-Raye Teo Qi-Wen; Menachem Viktor Sarusie; Flora Rajaei; Christoph Winkler
Journal:  Mol Endocrinol       Date:  2014-12-09

9.  Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.

Authors:  Masaaki Yamamoto; Anat Ben-Shlomo; Hiraku Kameda; Hidenori Fukuoka; Nan Deng; Yan Ding; Shlomo Melmed
Journal:  JCI Insight       Date:  2018-10-04

10.  The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling.

Authors:  Lionel Budry; Aurélio Balsalobre; Yves Gauthier; Konstantin Khetchoumian; Aurore L'honoré; Sophie Vallette; Thierry Brue; Dominique Figarella-Branger; Björn Meij; Jacques Drouin
Journal:  Genes Dev       Date:  2012-10-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.